Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"

Capecchi, Pier Leopoldo; Lazzerini, Pietro Enea; Brillanti, Stefano

Capecchi, Pier Leopoldo; Lazzerini, Pietro Enea; Brillanti, Stefano.

Capecchi PL; Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy; Unit of Internal and Emergency Medicine, Azienda Ospedaliero-Universitaria Senese - AOUS, Siena, Italy. Electronic address: capecchipl@unisi.it.
Lazzerini PE; Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy; Unit of Internal and Emergency Medicine, Azienda Ospedaliero-Universitaria Senese - AOUS, Siena, Italy.
Brillanti S; Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy; Unit of Hepatology, Azienda Ospedaliero-Universitaria Senese - AOUS, Siena, Italy.

J Hepatol ; 75(4): 994-995, 2021 10.

Article in English | MEDLINE | ID: covidwho-1370589

Subject(s)

COVID-19; Hepatitis, Autoimmune; COVID-19 Vaccines; Causality; Humans; SARS-CoV-2

Keywords

Autoimmune Hepatitis; COVID-19 vaccine; pregnancy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis, Autoimmune / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google